These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12581745)

  • 1. Evidence for cytoskeletal changes secondary to plasma membrane functional alterations in the in vitro cell response to Clostridium perfringens epsilon-toxin.
    Donelli G; Fiorentini C; Matarrese P; Falzano L; Cardines R; Mastrantonio P; Payne DW; Titball RW
    Comp Immunol Microbiol Infect Dis; 2003 May; 26(3):145-56. PubMed ID: 12581745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Clostridium perfringens epsilon toxin on MDCK cells.
    Borrmann E; Günther H; Köhler H
    FEMS Immunol Med Microbiol; 2001 Aug; 31(2):85-92. PubMed ID: 11549414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphological alterations in MDCK cells induced by exposure to Clostridium perfringens epsilon-toxin.
    Hambrook JL; Lindsay CD; Hughes N
    Biochem Soc Trans; 1995 Feb; 23(1):44S. PubMed ID: 7758757
    [No Abstract]   [Full Text] [Related]  

  • 4. Clostridium perfringens epsilon-toxin acts on MDCK cells by forming a large membrane complex.
    Petit L; Gibert M; Gillet D; Laurent-Winter C; Boquet P; Popoff MR
    J Bacteriol; 1997 Oct; 179(20):6480-7. PubMed ID: 9335299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional analysis of neutralizing antibodies against Clostridium perfringens epsilon-toxin.
    McClain MS; Cover TL
    Infect Immun; 2007 Apr; 75(4):1785-93. PubMed ID: 17261609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clostridium perfringens epsilon toxin induces a rapid change of cell membrane permeability to ions and forms channels in artificial lipid bilayers.
    Petit L; Maier E; Gibert M; Popoff MR; Benz R
    J Biol Chem; 2001 May; 276(19):15736-40. PubMed ID: 11278669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridium perfringens epsilon toxin rapidly decreases membrane barrier permeability of polarized MDCK cells.
    Petit L; Gibert M; Gourch A; Bens M; Vandewalle A; Popoff MR
    Cell Microbiol; 2003 Mar; 5(3):155-64. PubMed ID: 12614459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An assessment of the in vitro toxicology of Clostridium perfringens type D epsilon-toxin in human and animal cells.
    Shortt SJ; Titball RW; Lindsay CD
    Hum Exp Toxicol; 2000 Feb; 19(2):108-16. PubMed ID: 10773840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of aspects of the toxicity of Clostridium perfringens epsilon-toxin using the MDCK cell line.
    Lindsay CD
    Hum Exp Toxicol; 1996 Nov; 15(11):904-8. PubMed ID: 8938486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance of ovine, caprine and bovine endothelial cells to Clostridium perfringens type D epsilon toxin in vitro.
    Uzal FA; Rolfe BE; Smith NJ; Thomas AC; Kelly WR
    Vet Res Commun; 1999 Aug; 23(5):275-84. PubMed ID: 10493114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a new cytotoxicity assay for Clostridium perfringens type D epsilon toxin.
    Payne DW; Williamson ED; Havard H; Modi N; Brown J
    FEMS Microbiol Lett; 1994 Feb; 116(2):161-7. PubMed ID: 7512061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assembly of Clostridium perfringens epsilon-toxin on MDCK cell membrane.
    Nagahama M; Ochi S; Sakurai J
    J Nat Toxins; 1998 Oct; 7(3):291-302. PubMed ID: 9783265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligomer formation of Clostridium perfringens epsilon-toxin is induced by activation of neutral sphingomyelinase.
    Takagishi T; Oda M; Takehara M; Kobayashi K; Nagahama M
    Biochim Biophys Acta; 2016 Nov; 1858(11):2681-2688. PubMed ID: 27453200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for a prepore stage in the action of Clostridium perfringens epsilon toxin.
    Robertson SL; Li J; Uzal FA; McClane BA
    PLoS One; 2011; 6(7):e22053. PubMed ID: 21814565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of Clostridium perfringens epsilon-toxin with biological and model membranes: A putative protein receptor in cells.
    Manni MM; Sot J; Goñi FM
    Biochim Biophys Acta; 2015 Mar; 1848(3):797-804. PubMed ID: 25485476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the high affinity binding of epsilon toxin from Clostridium perfringens to the renal system.
    Dorca-Arévalo J; Martín-Satué M; Blasi J
    Vet Microbiol; 2012 May; 157(1-2):179-89. PubMed ID: 22264388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epsilon toxin from Clostridium perfringens induces cytotoxicity in FRT thyroid epithelial cells.
    Dorca-Arévalo J; Blanch M; Pradas M; Blasi J
    Anaerobe; 2018 Oct; 53():43-49. PubMed ID: 29895394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The early effects of Clostridium perfringens type D epsilon toxin in ligated intestinal loops of goats and sheep.
    Fernandez Miyakawa ME; Uzal FA
    Vet Res Commun; 2003 Apr; 27(3):231-41. PubMed ID: 12777097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dominant-negative inhibitors of the Clostridium perfringens epsilon-toxin.
    Pelish TM; McClain MS
    J Biol Chem; 2009 Oct; 284(43):29446-53. PubMed ID: 19720828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production and evaluation of a monoclonal antibody to Clostridium perfringens type D epsilon toxin.
    El-Enbaawy MI; Abdalla YA; Hussein AZ; Osman RM; Selim SA
    Egypt J Immunol; 2003; 10(1):77-81. PubMed ID: 15719625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.